News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,766 Results
Type
Article (13806)
Company Profile (101)
Press Release (251859)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88060)
Career Advice (465)
Deals (15344)
Drug Delivery (67)
Drug Development (36607)
Employer Resources (49)
FDA (6297)
Job Trends (6201)
News (150247)
Policy (14042)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (33)
Alliances (23230)
ALS (36)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (41)
Approvals (6333)
Artificial intelligence (107)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (20)
Brain cancer (16)
Breast cancer (78)
Cancer (612)
Cardiovascular disease (72)
Career advice (408)
Career pathing (12)
CAR-T (22)
Cell therapy (88)
Cervical cancer (4)
Clinical research (30930)
Collaboration (344)
Compensation (155)
Complete response letters (17)
COVID-19 (757)
CRISPR (20)
C-suite (124)
Cystic fibrosis (37)
Data (639)
Denatured (15)
Depression (9)
Diabetes (81)
Diagnostics (1319)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (65)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32144)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37514)
Executive appointments (392)
FDA (6718)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (215)
Gene editing (38)
Generative AI (9)
Gene therapy (100)
GLP-1 (349)
Government (1299)
Grass and pollen (3)
Guidances (16)
Healthcare (3564)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (14)
Infectious disease (792)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (59)
IPO (5878)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (180)
Leadership (3)
Legal (3433)
Liver cancer (19)
Lung cancer (82)
Lymphoma (55)
Machine learning (1)
Management (16)
Manufacturing (158)
MASH (32)
Medical device (1276)
Medtech (1278)
Mergers & acquisitions (9674)
Metabolic disorders (262)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (578)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (712)
Now hiring (8)
Obesity (150)
Opinion (119)
Ovarian cancer (21)
Pain (51)
Pancreatic cancer (14)
Parkinson's disease (46)
Partnered (7)
Patents (117)
Patient recruitment (29)
Peanut (10)
People (28959)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8048)
Phase II (13088)
Phase III (11742)
Pipeline (445)
Policy (71)
Postmarket research (1401)
Preclinical (3220)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (168)
Real estate (2637)
Recruiting (17)
Regulatory (10119)
Reports (14)
Research institute (565)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (37)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Southern California (726)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1629)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (26)
The Weekly (30)
United States (7260)
Vaccines (153)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (3)
Date
Today (78)
Last 7 days (202)
Last 30 days (907)
Last 365 days (11810)
2025 (3625)
2024 (12501)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20131)
Australia (2615)
California (1730)
Canada (911)
China (239)
Colorado (69)
Connecticut (68)
Delaware (56)
Europe (39456)
Florida (329)
Georgia (38)
Idaho (9)
Illinois (196)
India (16)
Indiana (135)
Iowa (1)
Japan (93)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (258)
Massachusetts (1496)
Michigan (30)
Minnesota (95)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (769)
New Mexico (7)
New York (513)
North Carolina (395)
North Dakota (2)
Northern California (712)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (445)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (726)
Tennessee (34)
Texas (233)
Utah (33)
Virginia (75)
Washington D.C. (31)
Washington State (119)
Wisconsin (16)
265,766 Results for "eyepoint pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 16, 2025
April 17, 2025
·
2 min read
Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 17, 2025
March 18, 2025
·
3 min read
Press Releases
EyePoint Announces Participation at Upcoming March 2025 Investor Conferences
March 5, 2025
·
2 min read
Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - February 17, 2025
February 17, 2025
·
3 min read
Press Releases
EyePoint to Present at Guggenheim SMID Cap Biotech Conference
January 30, 2025
·
2 min read
Genetown
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
EyePoint Pharmaceuticals, Inc. today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 3:20 p.m. ET.
June 5, 2024
·
1 min read
Genetown
EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
EyePoint Pharmaceuticals, Inc. today announced that the Company will host an R&D Day on Wednesday, June 26, 2024 from 8:00 a.m. to 9:30 a.m. ET.
June 18, 2024
·
2 min read
Press Releases
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
2 min read
Genetown
EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024
EyePoint Pharmaceuticals, Inc. today announced the Company will highlight clinical and regulatory developments for its lead pipeline program, DURAVYU™.
June 26, 2024
·
11 min read
Press Releases
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
November 5, 2024
·
2 min read
1 of 26,577
Next
